Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer. Hosokawa A, Yamada R, Otsuki Y, Tamura H, et al. Anticancer Res 2025;45:5069-5076.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hosokawa A, Yamada R, Otsuki Y, Tamura H, et al. Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer. Anticancer Res 2025;45:5069-5076.
PMID: 41151871